0
0
Home » Medical Devices » Cardiovascular Devices

Coronary Artery Bypass Graft Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update

Coronary artery bypass graft surgery devices are used in the surgery to improve blood flow to the obstructed coronary artery. Surgeons use these devices to treat people who have severe coronary heart disease. GlobalData’s report provides comprehensive information about the coronary artery bypass graft surgery devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key information and data related to major pipeline products which include product description, licensing and collaboration details, and other developmental activities such as pipeline territories, regulatory paths, and estimated approval dates. The report contains key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major coronary artery bypass graft surgery devices pipeline products.

What is the territory outlook in the coronary artery bypass graft surgery devices pipeline products market?

The US accounts for the highest number of pipeline products in the market followed by Europe, Israel, and Canada.

Coronary artery bypass graft surgery devices pipeline products to market, by regions

Coronary artery bypass graft surgery devices pipeline products to market, by regions

For more regional insights, download a free report sample

What are the segments in the coronary artery bypass graft surgery devices pipeline products market?

The key segments in the coronary artery bypass graft surgery devices pipeline products market are based on stages of development, regulatory path, estimated approval date, and ongoing clinical trials. As of December 2021, most of the pipeline products in the market are in the inactive stage. Early development, pre-clinical and clinical account for less than 5 products in the market each. The maximum number of pipeline products will be approved in 2024. In 2028, 2 products in the pipelines will be approved by the first quarter of the year.

Coronary artery bypass graft surgery devices pipeline products market, by stages of development

Coronary artery bypass graft surgery devices pipeline products market, by stages of development

For more segment insights, download a free report sample

Which are the major companies in the coronary artery bypass graft surgery devices pipeline products market?

The key companies in the coronary artery bypass graft surgery devices pipeline products market are AdvanSource Biomaterials Corporation, ArtiFex Medical GmbH, Axcelon Biopolymers Corp, CardioPolymers Inc, Cardious Inc, Centre Hospitalier Universitaire de Nice, Coromedic Ltd., Cytograft Tissue Engineering Inc (Inactive), Elana bv, enVVeno Medical Corp, Graft-Loc Inc., H. Lee Moffitt Cancer Center & Research Institute Inc, iiTech BV, McGill University, and Medical 21 Inc.

Company Overview

AdvanSource Biomaterials Corporation: It develops polymer materials, used in the design and development of medical devices. The company primarily offers products such as chronoFlex AL, chornoFlex AR, Chrono sil, hydroMed, and polyBlend. AdvanSource’s services include customized materials, product extension, custom solutions, and project management. Its biomaterial products are used in devices that are designed for treating a range of anatomical sites and disease states. The company has its presence in the US, Canada, China, India, and Egypt. AdvanSource is headquartered in Wilmington, Massachusetts, the US.

ArtiFex Medical GmbH: ArtiFex Medical GmbH (ArtiFex) develops grafts for cardiovascular bypasses and is headquartered in Vienna, Austria.

Axcelon Biopolymers Corp: They are an innovative biomaterials company focused on leveraging its unique bacterial nanocellulose platform technology to develop high-value products for wound care, medical devices, tissue engineering, and industrial applications. The company is in London, Ontario, Canada.

CardioPolymers Inc: The company develops biocompatible polymer implant therapies. It helps to treat chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation. It is headquartered in Laguna Hills, California.

Cardious Inc: It is a medical device company that offers valve bypass graft systems. The company offers minimally invasive heart valve therapies. It provides implant and associated tools needed to relieve aortic valve disease. Cardious’ proprietary product aortic valve bypass graft system is a minimally invasive alternative to traditional aortic valve replacement therapy. The company’s valve bypass graft systems are used as a beating heart alternative to traditional aortic valve replacement therapy. It caters to cardiac surgeons, hospitals, and medical centers. The company markets its products across the US. Cardious is headquartered in Northfield, Minnesota, the US.

Coronary artery bypass graft surgery devices pipeline products market, by key players

Coronary artery bypass graft surgery devices pipeline products market, by key players

To know more about key players, download a free report sample

Market report scope

Key countries The US, Europe, Israel, and Canada

 

Key stages of development Early Development, Pre-clinical, Clinical, and Inactive
Key companies AdvanSource Biomaterials Corporation, ArtiFex Medical GmbH, Axcelon Biopolymers Corp, CardioPolymers Inc, Cardious Inc, Centre Hospitalier Universitaire de Nice, Coromedic Ltd., Cytograft Tissue Engineering Inc (Inactive), Elana bv, enVVeno Medical Corp, Graft-Loc Inc., H. Lee Moffitt Cancer Center & Research Institute Inc, iiTech BV, McGill University, and Medical 21 Inc

This report provides an in-depth analysis of:

  • Coronary artery bypass graft surgery devices under development
  • Details of major pipeline products, which includes, product description, licensing and collaboration details, and other developmental activities
  • Major players involved in the development of coronary artery bypass graft surgery devices and lists all their pipeline projects
  • Pipeline products based on various stages of development ranging from early development to approved/issued stage
  • Key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulation of significant competitor information, analysis, and insights to improve R&D strategies
  • Identification of emerging players with potentially strong product portfolios and creating effective counter-strategies to gain a competitive advantage
  • Identification and understanding of important and diverse types of coronary artery bypass graft surgery devices under development
  • Development of market-entry and market expansion strategies
  • Planning mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Key Players

AdvanSource Biomaterials Corporation

ArtiFex Medical GmbH

Axcelon Biopolymers Corp

CardioPolymers Inc

Cardious Inc

Centre Hospitalier Universitaire de Nice

Coromedic Ltd.

Cytograft Tissue Engineering Inc (Inactive)

Elana bv

enVVeno Medical Corp

Graft-Loc Inc.

H. Lee Moffitt Cancer Center & Research Institute Inc

iiTech BV

McGill University

Medical 21 Inc

Myocardial Assist Systems and Technology LLC

Neograft Technologies Inc

PetVivo Holdings Inc

Prekubator TTO

RegenMedTX LLC

Rox Medical Inc

SeamVad Ltd.

Surg Solutions SL

Synovis Micro Companies Alliance Inc

Thoratec LLC

Tissue Regeneration Technologies LLC

University College London

University of Arizona

University of California Los Angeles

Xeltis AG

Table of Contents

1 Table of Contents

2 Introduction 9

2.1 Coronary Artery Bypass Graft Surgery Overview 9

3 Products under Development 10

3.1 Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 10

3.2 Coronary Artery Bypass Graft Surgery – Pipeline Products by Territory 11

3.3 Coronary Artery Bypass Graft Surgery – Pipeline Products by Regulatory Path 12

3.4 Coronary Artery Bypass Graft Surgery – Pipeline Products by Estimated Approval Date 13

3.5 Coronary Artery Bypass Graft Surgery – Ongoing Clinical Trials 14

4 Coronary Artery Bypass Graft Surgery – Pipeline Products under Development by Companies 15

4.1 Coronary Artery Bypass Graft Surgery Companies – Pipeline Products by Stage of Development 15

4.2 Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 17

5 Coronary Artery Bypass Graft Surgery Companies and Product Overview 18

5.1 AdvanSource Biomaterials Corporation Company Overview 18

5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18

5.2 ArtiFex Medical GmbH Company Overview 19

5.2.1 ArtiFex Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Axcelon Biopolymers Corp Company Overview 20

5.3.1 Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 CardioPolymers Inc Company Overview 21

5.4.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Cardious Inc Company Overview 22

5.5.1 Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Centre Hospitalier Universitaire de Nice Company Overview 23

5.6.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Coromedic Ltd. Company Overview 24

5.7.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Cytograft Tissue Engineering Inc (Inactive) Company Overview 26

5.8.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Elana bv Company Overview 27

5.9.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 enVVeno Medical Corp Company Overview 28

5.10.1 enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 Graft-Loc Inc. Company Overview 31

5.11.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 32

5.12.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.13 iiTech BV Company Overview 33

5.13.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 McGill University Company Overview 35

5.14.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 35

5.15 Medical 21 Inc Company Overview 36

5.15.1 Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.16 Myocardial Assist Systems and Technology LLC Company Overview 37

5.16.1 Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 Neograft Technologies Inc Company Overview 38

5.17.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.18 PetVivo Holdings Inc Company Overview 39

5.18.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.19 Prekubator TTO Company Overview 40

5.19.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 40

5.20 RegenMedTX LLC Company Overview 41

5.20.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.21 Rox Medical Inc Company Overview 42

5.21.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.22 SeamVad Ltd. Company Overview 45

5.22.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45

5.23 Surg Solutions SL Company Overview 46

5.23.1 Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 46

5.24 Synovis Micro Companies Alliance Inc Company Overview 47

5.24.1 Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.25 Thoratec LLC Company Overview 48

5.25.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.26 Tissue Regeneration Technologies LLC Company Overview 49

5.26.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.27 University College London Company Overview 50

5.27.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 50

5.28 University of Arizona Company Overview 51

5.28.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 51

5.29 University of California Davis Company Overview 52

5.29.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 52

5.30 University of California Los Angeles Company Overview 53

5.30.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

5.31 Xeltis AG Company Overview 54

5.31.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 54

6 Coronary Artery Bypass Graft Surgery- Recent Developments 57

6.1 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 57

6.2 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 57

6.3 Apr 28, 2022: LeMaitre Q1 2022 Financial Results 58

6.4 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022 59

6.5 Apr 11, 2022: AtriCure to Announce First Quarter 2022 Financial Results 59

6.6 Feb 24, 2022: LeMaitre Q4 2021 Financial Results 59

6.7 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022 61

6.8 Jan 13, 2022: Getinge program recognizes dedicated North American vessel harvesters 61

6.9 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 62

6.10 Nov 17, 2021: French biotech CellProthera welcomes three exceptional talents to its executive management team 62

6.11 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 63

6.12 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER 63

6.13 Oct 28, 2021: LeMaitre Q3 2021 Financial Results 73

6.14 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 74

6.15 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021 78

6.16 Sep 09, 2021: Etiometry and Terumo Cardiovascular announce partnership to deliver enhanced monitoring insights for adult cardiac surgery patients 79

6.17 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 79

6.18 Aug 04, 2021: AtriCure Reports Second Quarter 2021 Financial Results 80

6.19 Jul 30, 2021: AtriCure to Participate at the Canaccord 41st Annual Growth Conference 81

6.20 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021 81

6.21 Jul 29, 2021: LeMaitre Q2 2021 Financial Results 81

6.22 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August 82

7 Appendix 83

7.1 Methodology 83

7.2 About GlobalData 86

7.3 Contact Us 86

7.4 Disclaimer 86

List of Tables

Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 10

Coronary Artery Bypass Graft Surgery – Pipeline Products by Territory 11

Coronary Artery Bypass Graft Surgery – Pipeline Products by Regulatory Path 12

Coronary Artery Bypass Graft Surgery – Pipeline Products by Estimated Approval Date 13

Coronary Artery Bypass Graft Surgery – Ongoing Clinical Trials 14

Coronary Artery Bypass Graft Surgery Companies – Pipeline Products by Stage of Development 15

Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 17

AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 18

CardioPass – Product Status 18

CardioPass – Product Description 18

ArtiFex Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

ArtiFex Vascular Graft – Product Status 19

ArtiFex Vascular Graft – Product Description 19

Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 20

BNC – PVA Based Vascular Graft – Product Status 20

BNC – PVA Based Vascular Graft – Product Description 20

CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Plexisyl-AF – Product Status 21

Plexisyl-AF – Product Description 21

Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 22

AvA Aortic Valve Bypass Graft System – Product Status 22

AvA Aortic Valve Bypass Graft System – Product Description 22

Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 23

Shark Anastomosis Connector – Product Status 23

Shark Anastomosis Connector – Product Description 23

Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24

Distal Anastomosis Device – Product Status 24

Distal Anastomosis Device – Product Description 24

Proximal Anastomosis Device – Product Status 25

Proximal Anastomosis Device – Product Description 25

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 26

LifeLine TEBV – CABG – Product Status 26

LifeLine TEBV – CABG – Product Description 26

Elana bv Pipeline Products & Ongoing Clinical Trials Overview 27

ELANA CLIP 3.0 – Product Status 27

ELANA CLIP 3.0 – Product Description 27

enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 28

CoreoGraft – Product Status 28

CoreoGraft – Product Description 28

enVVeno Medical Corp – Ongoing Clinical Trials Overview 29

CoreoGraft – First-in-human Trial Evaluating the Efficacy of CoreoGraft in the Coronary Artery Bypass Graft (CABG) Surgery 30

Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

Graft-Loc Device – Product Status 31

Graft-Loc Device – Product Description 31

H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Vascular Stent – Product Status 32

Vascular Stent – Product Description 32

iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 33

S² Distal Anastomotic System – Product Status 33

S² Distal Anastomotic System – Product Description 33

S² Proximal Anastomotic System – Product Status 34

S² Proximal Anastomotic System – Product Description 34

McGill University Pipeline Products & Ongoing Clinical Trials Overview 35

Transcatheter Aorta Pulmonary Shunt – Product Status 35

Transcatheter Aorta Pulmonary Shunt – Product Description 35

Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Artificial Blood Vessel – Product Status 36

Artificial Blood Vessel – Product Description 36

Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Sutureless Anastomotic Graft Connection Device – Product Status 37

Sutureless Anastomotic Graft Connection Device – Product Description 37

Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Neovaso – Product Status 38

Neovaso – Product Description 38

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Coronary Artery Bypass Graft – Product Status 39

Coronary Artery Bypass Graft – Product Description 39

Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 40

Snapcon – Product Status 40

Snapcon – Product Description 40

RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 41

Neo-Vessel Replacement – Coronary Artery Bypass – Product Status 41

Neo-Vessel Replacement – Coronary Artery Bypass – Product Description 41

Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

ROX Anastomotic Coupler System – Product Status 42

ROX Anastomotic Coupler System – Product Description 42

Rox Medical Inc – Ongoing Clinical Trials Overview 43

ROX Anastomotic Coupler System – The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study 44

SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45

MySide – Product Status 45

MySide – Product Description 45

Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 46

VessConnect – Product Status 46

VessConnect – Product Description 46

Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Arterial Everter – Product Status 47

Arterial Everter – Product Description 47

Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Automated Anastomosis Device – Product Status 48

Automated Anastomosis Device – Product Description 48

Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Cardiogold – Product Status 49

Cardiogold – Product Description 49

University College London Pipeline Products & Ongoing Clinical Trials Overview 50

Small Diameter Conduit – Product Status 50

Small Diameter Conduit – Product Description 50

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 51

Vascular Anastomosis Device – Product Status 51

Vascular Anastomosis Device – Product Description 51

University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 52

Vascular Anastomosis Device – Product Status 52

Vascular Anastomosis Device – Product Description 52

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 53

Sutureless Anastomosis Device – Product Status 53

Sutureless Anastomosis Device – Product Description 53

Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 54

Xeltis Coronary Artery Bypass Graft – Product Status 54

Xeltis Coronary Artery Bypass Graft – Product Description 54

Xeltis AG – Ongoing Clinical Trials Overview 55

Xeltis Coronary Artery Bypass Graft – Prospective, Non-randomized, First in Human (FIH) Clinical Study to Assess the Feasibility of the Novel Xeltis Coronary Artery Bypass Graft (XABG) 56

Glossary 85

List of Figures

Coronary Artery Bypass Graft Surgery – Pipeline Products by Stage of Development 10

Coronary Artery Bypass Graft Surgery – Pipeline Products by Territory 11

Coronary Artery Bypass Graft Surgery – Pipeline Products by Regulatory Path 12

Coronary Artery Bypass Graft Surgery – Pipeline Products by Estimated Approval Date 13

Coronary Artery Bypass Graft Surgery – Ongoing Clinical Trials 14

Frequently Asked Questions

The key countries in the coronary artery bypass graft surgery devices pipeline products market are the US, Europe, Israel, and Canada.

The key stages of development in this market are early development, pre-clinical, clinical, and inactive.

Key companies in the coronary artery bypass graft surgery devices pipeline products market are AdvanSource Biomaterials Corporation, ArtiFex Medical GmbH, Axcelon Biopolymers Corp, CardioPolymers Inc, Cardious Inc, Centre Hospitalier Universitaire de Nice, Coromedic Ltd., Cytograft Tissue Engineering Inc (Inactive), Elana bv, enVVeno Medical Corp, Graft-Loc Inc., H. Lee Moffitt Cancer Center & Research Institute Inc, iiTech BV, McGill University, and Medical 21 Inc.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports